Kim Brøsen

Citeret af

	Alle	Siden 2019
Henvisninger	20937	3372
h-index	83	29
i10-indeks	226	96

820

410

205

615

19891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202487 101 125 204 333 326 361 506 539 560 613 605 668 642 736 805 739 761 736 711 818 675 677 672 749 647 706 685 583 661 641 621 593 593 477 443

Offentlig adgang

Se alle

28 artikler

6 artikler

tilgængelige

ikke tilgængelige

Baseret på krav i forbindelse med finansiering

Medforfattere

Per DamkierVerificeret mail på health.sdu.dk
Tore B. StageProfessor, Translational Pharmacology, University of Southern DenmarkVerificeret mail på health.sdu.dk
Troels K BergmannAssociate professor, University of Southern Denmark, Odense, DenmarkVerificeret mail på rsyd.dk
Lars Arendt-NielsenDirector, professor, dr med sci, ph dVerificeret mail på hst.aau.dk
Jesper HallasUniversity of Southern DenmarkVerificeret mail på health.sdu.dk
Henrik E. PoulsenProfessor Klinisk FarmakologiVerificeret mail på rh.dk
Steffen LoftUniversity of Copenhagen, Department of Public HealthVerificeret mail på sund.ku.dk
Henrik GreenLinköping University Verificeret mail på liu.se
Niels JessenProfessor of Clinical Pharmacology, Aarhus UniversitetVerificeret mail på clin.au.dk
Troels Staehelin JensenProfessor of Neurology, Aarhus UniversityVerificeret mail på clin.au.dk
Werner VachSenior Researcher in Applied Methodology, Basel Academy for Quality and Research in MedicineVerificeret mail på crossklinik.ch
Mansoor Raza MirzaNordic Society of Gynaecological Oncology & Rigshospitalet, Copenhagen, DenmarkVerificeret mail på regionh.dk
Søren Mikkelsen, Professor, MD PhDPrehospital Research Unit, the Region of Southern Denmark, Odense University Hospital, DenmarkVerificeret mail på rsyd.dk
Jorgen FrokiaerProfessor i medicin, Aarhus UniversitetVerificeret mail på ki.au.dk
Mogens HorderUniversity of Southern DenamrkVerificeret mail på health.sdu.dk
Lars Christian GormsenLektor, overlæge, Aarhus UniversitetshospitalVerificeret mail på rm.dk
Peter BjerringProfessor, Department of Dermatology, Aalborg University HospitalVerificeret mail på peterbjerring.dk
Anton PottegårdProfessor, University of Southern DenmarkVerificeret mail på health.sdu.dk
Kim BrixenMedical Director, Odense University HospitalVerificeret mail på rsyd.dk
Ivar S KristiansenProfessor of community medicine University of OsloVerificeret mail på medisin.uio.no

Følg

Kim Brøsen

Professor in Clinical Pharmacology, University of Southern Denmark

Verificeret mail på health.sdu.dk - Startside

Pharmacogenetics drug metabolism dry-drug interactions pharmacogenetics


Titel Sortér efter henvisninger Sortér efter årstal Sortér efter titel	Citeret af Citeret af	År
The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms SH Sindrup, LF Gram, K Brøsen, O Eshøj, EF Mogensen Pain 42 (2), 135-144, 1990	641	1990
CYP2D6 and CYP2C19 genotype‐based dose recommendations for antidepressants: a first step towards subpopulation‐specific dosages J Kirchheiner, K Brøsen, ML Dahl, LF Gram, S Kasper, I Roots, F Sjöqvist, ... Acta Psychiatrica Scandinavica 104 (3), 173-192, 2001	575	2001
Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study Danish University Antidepressant Group Journal of Affective Disorders 18 (4), 289-299, 1990	564	1990
The hypoalgesic effect of tramadol in relation to CYP2D6 L Poulsen, L Arendt‐Nielsen, K Brøsen, SH Sindrup Clinical Pharmacology & Therapeutics 60 (6), 636-644, 1996	495	1996
Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial SH Sindrup, G Andersen, C Madsen, T Smith, K Brøsen, TS Jensen Pain 83 (1), 85-90, 1999	484	1999
Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention J Hallas, B Harvald, LF Gram, E Grodum, K Brøsen, T Haghfelt, N Damsbo Journal of internal medicine 228 (2), 83-90, 1990	480	1990
Fluvoxamine is a potent inhibitor of cytochrome P4501A2 K Brøsen, E Skjelbo, BB Rasmussen, HE Poulsen, S Loft Biochemical pharmacology 45 (6), 1211-1214, 1993	447	1993
Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine U Jeppesen, LF Gram, K Vistisen, S Loft, HE Poulsen, K Brøsen European journal of clinical pharmacology 51, 73-78, 1996	430	1996
The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy SH Sindrup, U Bjerre, A Dejgaard, K Brøsen, T Aaes‐Jørgensen, LF Gram Clinical Pharmacology & Therapeutics 52 (5), 547-552, 1992	392	1992
Clinical significance of the sparteine/debrisoquine oxidation polymorphism K Brøsen, LF Gram European Journal of Clinical Pharmacology 36, 537-547, 1989	381	1989
The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c MMH Christensen, C Brasch-Andersen, H Green, F Nielsen, P Damkier, ... Pharmacogenetics and genomics 21 (12), 837-850, 2011	315	2011
Drug related admissions to medical wards: a population based survey. J Hallas, LF Gram, E Grodum, N Damsbo, K Brosen, T Haghfelt, B Harvald, ... British journal of clinical pharmacology 33 (1), 61-68, 1992	314	1992
Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects L Poulsen, K Brøsen, L Arendt-Nielsen, LF Gram, K Elbaek, SH Sindrup European journal of clinical pharmacology 51, 289-295, 1996	313	1996
The interindividual differences in the 3-demthylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors BB Rasmussen, TH Brix, KO Kyvik, K Brøsen Pharmacogenetics and Genomics 12 (6), 473-478, 2002	286	2002
Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphisms SH Sindrup, K Brøsen, MGJ Hansen, T Aaes-Jørgensen, KF Overø, ... Therapeutic drug monitoring 15 (1), 11-17, 1993	278	1993
The relationship between paroxetine and the sparteine oxidation polymorphism SH Sindrup, K Brøsen, LF Gram, J Hallas, E Skjelbo, A Allen, GD Allen, ... Clinical Pharmacology & Therapeutics 51 (3), 278-287, 1992	259	1992
The pharmacogenetics of codeine hypoalgesia SH Sindrup, K Brøsen Pharmacogenetics and Genomics 5 (6), 335-346, 1995	253	1995
Recent developments in hepatic drug oxidation implications for clinical pharmacokinetics K Brosen Clinical pharmacokinetics 18, 220-239, 1990	250	1990
Inhibition by paroxetine of desipramine metabolism in extensive but not in poor metabolizers of sparteine K Brøsen, JG Hansen, KK Nielsen, SH Sindrup, LF Gram European journal of clinical pharmacology 44, 349-355, 1993	240	1993
Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine P Damkier, LL Hansen, K Brøsen British journal of clinical pharmacology 48 (6), 829-838, 1999	226	1999

Systemet kan ikke foretage handlingen nu. Prøv igen senere.

Artikler 1–20

Henvisninger pr. år

Dublerede henvisninger

Flettede henvisninger

Tilføj medforfattereMedforfattere

Følg

Citeret af

Medforfattere